DUBLIN, Apr. 15, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/2bf9l6/united_states) has announced the addition of the "United States Off-Label Drugs Market & Forecast" report to their offering.

This study titled United States Off-Label Drugs Market & Forecast report provides a comprehensive analysis of the emerging Off-Label Drugs market. The report also entails commonly prescribed Off-Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off-label Promotion Settlements under the False Claims Act. The report also studies Drivers and Challenges of United States Off-Label Drugs market.

The 6 Off-Label Drugs Segment Covered in the Report are as Follows:

1. Cancer Off-Label Drugs
2. Central Nervous System (CNS) Off-Label Drugs
3. Anti-Ashmatics Off-Label Drugs
4. Anti-Allergies Off-Label Drugs
5. Anti-Hypertensives Off-Label Drugs
6. Anti-Infectives Off-Label Drugs

Key Topics Covered:

1. Executive Summary

2. United States Off-Label Drugs Market & Forecast

3. United States Off-Label Drugs Market Share & Forecast

4. United States Off-Label Drugs Market - Segment wise

4.1 United States - Cancer Off-Label Drugs Market & Forecast
4.2 United States - Central Nervous System (CNS) Off-Label Drugs Market & Forecast
4.3 United States - Anti-Ashmatics Off-Label Drugs Market & Forecast
4.4 United States - Anti-Allergies Off-Label Drugs Market & Forecast
4.5 United States - Anti-Hypertensives Off-Label Drugs Market & Forecast
4.6 United States - Anti-Infectives Off-Label Drugs Market & Forecast

5. Drugs Commonly Prescribed Off-Label

6. Off-Label Use of Medicine & Different Perspectives

6.1 Physicians Perspective
6.1.1 Physicians' Liability for Off-Label Prescriptions
6.2 Patients Perspective
6.3 Perspective of the Pharmaceutical Companies
6.4 Perspective of Regulatory Agencies

7. Off-Label Promotion Settlements Under The False Claims Act

7.1 Year 2004
7.2 Year 2005
7.3 Year 2006
7.4 Year 2007
7.5 Year 2008
7.6 Year 2009
7.7 Year 2010
7.8 Year 2011
7.9 Year 2012
7.10 Year 2013
7.11 Year 2014

8. United States Off-Label Drugs Market - Growth Drivers

8.1 Clinical Practices and Application in the Off-Label Drugs
8.2 Vulnerable Patient Populations: Information and Access
8.3 Off-Label Promotion Reform

9. United States Off-Label Drugs Market - Challenges

9.1 Lack of Regulation & Information of the United States Off-Label Drugs Market
9.2 Reimbursement
9.3 Safety and Efficacy of Unapproved and Under Evaluated Use
9.4 Point of View on Bioethical Off-Label Drugs Use
9.5 Inaccuracy of Off-Label Clinical Publications

For more information visit http://www.researchandmarkets.com/research/2bf9l6/united_states

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets